FISHMAN SARI

PrivateCIK: 2116402
InsiderFISHMAN SARICIK 2116402
IssuerCAN-FITE BIOPHARMA LTD.CIK 1536196
Officer· VP Business Development
Since Mar 2026
0.00
Baseline shares
0.00
Direct ownership
0 positions
6.45K
Derivative underlying
9 instruments
0
Security positions
All direct
Non-Derivative Holdings0
No non-derivative holdings reported
Derivative Holdings9

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

1.67K

Shares owned

N/A

Exercise price

25.21

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

333.00

Shares owned

N/A

Exercise price

241.47

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

500.00

Shares owned

N/A

Exercise price

247.36

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

1.67K

Shares owned

N/A

Exercise price

17.39

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

50.00

Shares owned

N/A

Exercise price

2427.24

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

26.00

Shares owned

N/A

Exercise price

3537.03

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

40.00

Shares owned

N/A

Exercise price

2264.01

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

1.67K

Shares owned

N/A

Exercise price

26.56

Expiration

Exercise window

Options to Purchase Ordinary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

500.00

Shares owned

N/A

Exercise price

241.47

Expiration

Exercise window

Total

Underlying

6.45K

Owned

0.00

FISHMAN SARI — Initial Ownership Disclosure (Form 3) Filed Mar 18, 2026 | Finecho